Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN37,7437,85-2,35
Msft-4,96
Nokia3,42153,463-3,05
IBM-3,54
Daimler AG44,1544,165-5,98
PFE-5,29
29.10.2020 1:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 28.10.2020 21:30:00
Marrone Bio Inn (NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
1,15 -2,54 -0,03 99 857
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 29.10.2020
Popis společnosti
Obecné informace
Název společnostiMarrone Bio Innovations Inc
TickerMBII
Kmenové akcie:Ordinary Shares
RICMBII.O
ISIN-
Poslední známé roční výsledky31.12.2019
Poslední známé čtvrtletní výsledky30.06.2020
Počet zaměstnanců k 31.12.2019 113
Akcie v oběhu k 16.09.2020 152 475 013
MěnaUSD
Kontaktní informace
Ulice1540 Drew Ave
MěstoDAVIS
PSČ95618-6320
ZeměUnited States
Kontatní osobaGreg Falesnik
Funkce kontaktní osobyManaging Director (MZ North America)
Telefon15 307 502 800
Fax13025313150
Kontatní telefon19 493 856 449

Business Summary: Marrone Bio Innovations, Inc. offers bio-based pest management and plant health products. The Company's bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene. Its products are used in both conventional and organic crop production, and are sold to growers of specialty crops, such as grapes, citrus, tomatoes, vegetables, nuts, leafy greens and ornamental plants. It offers Regalia for large-acre row crops, such as corn and soybeans. Its pipeline of early-stage discoveries and product candidates extends across a range of product types for end markets, including herbicides, fungicides, nematicides, insecticides, algaecides (for algae control), molluscicides (for mussel and snail control), and plant growth and plant stress regulators. It is engaged in developing MBI-010, MBI-110, Haven (MBI-505) and MBI-601.
Financial Summary: BRIEF: For the six months ended 30 June 2020, Marrone BioInnovations Inc revenues increased 39% to $21.8M. Net lossdecreased 7% to $9.9M. Revenues reflect an increase indemand for the Company's products and services due tofavorable market conditions. Lower net loss reflectsResearch and development decrease of 16% to $5.5M (expense), Other Income/Expense increase from $48K to $272K (income).
Odvětvová klasifikace
TRBC2009Chemicals - Agricultural
TRBC2012Agricultural Chemicals - NEC
MGINDUSTRYChemical Manufacturing
MGSECTORBasic Materials
NAICS2007Pesticide and Other Agricultural Chemical Manufacturing
NAICS1997Pesticide and Other Agricultural Chemical Manufacturing
SICAgricultural Chemicals, Nec



  • Poslední aktualizace: 29.10.2020
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Independent Chairman of the BoardRobert Woods7702.02.201802.02.2018
Chief Executive Officer, DirectorKevin Helash5603.08.202003.08.2020
Executive Vice President, Chief Compliance Officer, General Counsel, SecretaryLinda Moore7306.11.2017
Senior Vice President - Research and Development, Chief Technology OfficerAmit Vasavada6516.03.2017
Senior Vice President - Regulatory and Government Affairs, Chief Sustainability OfficerKeith Pitts5708.08.2016
Vice President - Field Development and Technical ServicesTimothy Johnson64
Chief Commercial OfficerKevin Hammill5307.05.201807.05.2018